Fundraising Fox

Vikas Goyal

Investor

Partner at Longwood Fund

Cambridge, Massachusetts, United States

About

Vikas Goyal left investing to run Pandion, leading partnerships, an IPO and Merck’s $1.85B acquisition; early backer of computational drug discovery who argues experimental data, not algorithms, is AI’s bottleneck.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Experience

  1. Longwood FundPartner, Growth Investmentscurrent2025 — presentBoston, Massachusetts, United States
  2. Longwood FundVenture Partner, Growth Investments2024 — 2025Boston, Massachusetts, United States
  3. Trekk Venture PartnersManaging Partner and Co-Founder2022 — 2024Boston, Massachusetts, United States
  4. Pandion therapeuticsMerck Integration2021Cambridge, Massachusetts, United States
  5. Pandion therapeuticsSVP Business Development2019 — 2021Cambridge, MA
  6. Pandion therapeuticsBoard Member2018 — 2019Cambridge, MA
  7. Morphic TherapeuticBoard Member2016 — 2021Waltham, MA
  8. Nimbus TherapeuticsBoard Member2018 — 2019Cambridge, MA
  9. Zikani TherapeuticsBoard Member2015 — 2019Watertown, MA
  10. CalciMedicaBoard Member2013 — 2019Greater San Diego Area
  11. SR OnePrincipal2011 — 2019
  12. Spero TherapeuticsBoard Member2014 — 2018Cambridge, MA
  13. Infinity PharmaceuticalsManager, Corporate Strategy & Development2010 — 2011
  14. SR OneIntern2009 — 2010
  15. Extera PartnersSenior Associate, Co-Founder2004 — 2008
  16. TiE Social EntrepreneursCo-Chair2006 — 2008
  17. PureTech VenturesAssociate, PureTech Development2004 — 2007
  18. McKinsey & CompanySenior Analyst2001 — 2003

Skills & more

Venture Capital99Financial Modeling15Entrepreneurship22Biotechnology45Start-ups38Due Diligence54Business Development15Mergers1Corporate Development11Life Sciences8Lifesciences1Mergers & Acquisitions24
+3 moreValuationStrategic PlanningStrategy

From Vikas's professional profile.

Investments

Board seats

Morphic TherapeuticsNimbus TherapeuticsPandionRiver Vision DevelopmentSpero Therapeutics

Per the firm's website.

Colleagues at Longwood Fund

Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Alex Margolin
Venture Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Annie Vemu
Senior Associate at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund

Frequently asked questions

Who is Vikas Goyal?
Vikas Goyal left investing to run Pandion, leading partnerships, an IPO and Merck’s $1.85B acquisition; early backer of computational drug discovery who argues experimental data, not algorithms, is AI’s bottleneck.
Where does Vikas Goyal work?
Vikas Goyal is Partner at Longwood Fund.
What does Vikas Goyal invest in?
Vikas Goyal invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
What boards does Vikas Goyal sit on?
Vikas Goyal holds tracked board seats at Morphic Therapeutics, Nimbus Therapeutics, Pandion, River Vision Development, Spero Therapeutics.
Where did Vikas Goyal go to school?
Vikas Goyal studied at The Wharton School (MBA, Business); University of Pennsylvania (MBA, Health Care Management); Harvard University (BA, Neurobiology).

Same school

Also attended The Wharton School1,557

Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of Atomic

+ 1,551 more

Also attended University of Pennsylvania824

Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners

+ 818 more

Also attended Harvard University1,558

Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGBill GatesCo-founder of Microsoft; Chair of the Gates Foundation

+ 1,552 more

Shared employers

Also worked at Morphic Therapeutic4

Amir NashatEntrepreneur partner at Polaris Partners focused on healthcare investing and portfolio company executive rolesKevin BittermanPartner at Atlas VentureMargarita ChavezManaging Director at AbbVieChristopher O'DonnellPartner at Pfizer Venture Investments

Also worked at Nimbus Therapeutics6

Erin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesAlex Badamchi-ZadehVice President at SV Health InvestorsRosana KapellerInvestor at GV (Google Ventures)Laura StoppelPartner at RA CapitalBrian GallagherPartner at SR One Capital Management

Also worked at SR One29

Freya Svedberg-KeatingInvestor at MedicxiJake BauerVenture Partner at ARCH Venture PartnersAleks Radovic-MorenoPartner at Longwood FundRajeev DadooCOO & Managing Partner at SR One Capital ManagementJake NunnPartner at SR One Capital ManagementPhilip HabibHead of Capital Partnering at SR One Capital Management

+ 23 more

Also worked at Infinity Pharmaceuticals11

Paul MeloneInvestor at Third Rock VenturesJeffrey TongPartner at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesSteve HoltzmanBio Advisor at Amplify PartnersAndrew PalmerCo-Founder of Tamr at Underscore VCDavid GrayzelPartner at Atlas Venture

+ 5 more